Brinzolamide
| Evidence Level: N/A | Predicted Indications: 0 |
Table of Contents
- Brinzolamide
Brinzolamide: Known uses and market status in Australia
Summary
The TxGNN model produced candidates for Brinzolamide, but every candidate that can be traced to a source is already a known use. There is currently no new predicted indication for this drug.
Quick overview
| Item | Content |
|---|---|
| New predicted indications | None (all traceable model candidates are known uses) |
| Known uses among model candidates | 1 |
| Evidence level | Not applicable |
| Australia Market Status | Listed on the PBS Schedule (1 of 1 items) – TGA (ARTG) registration status is not included in this data |
| Number of PBS Items | 1 (valid: 1) |
Known uses among the model’s candidates
Approved (supported by a licence or label)
| Indication | Source |
|---|---|
| primary hereditary glaucoma | licence in another country (approved indication: glaucoma) |
Related to an approved indication (same disease category)
| Indication | Approved category |
|---|---|
| none | none |
Relations recorded in the knowledge graph (no approval found)
| Indication |
|---|
| none |
Australia Market Information
| Licence | Product | Dosage form | Status |
|---|---|---|---|
| 14321R | Azopt | Eye drops 10 mg per mL, 5 mL | Valid |
Safety Considerations
Please refer to the TGA-approved Product Information (PI) for key warnings and contraindications, as this information was not available in the compiled data.
- Drug Interactions: The interaction query returned 32 potential interacting drugs, but none carries a severity rating (all classed as “Unknown”). Examples include pantoprazole, omeprazole, lansoprazole, prednisone, prednisolone, dexamethasone, simvastatin, rosuvastatin, warfarin and clopidogrel. These should be verified against the PI and a clinical interaction resource.
- Angle-closure concern: A recent case report described topical brinzolamide precipitating ciliary body effusion with secondary angle closure and myopic shift. Brinzolamide is a sulfonamide derivative, so caution is warranted.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.